Arthritis, Musculoskeletal and Skin Diseases Research in New York
Arthritis, Musculoskeletal and Skin Diseases Research (93.846) awarded $315 million to recipients in New York in 302 grants from fiscal 2021 to 2025, 12% of the program's national total. New York University received the most, $56.6 million.
- Awarded in New York$315 million
- Awards302
- Share of the program12%
- Rank among states2nd of 44
- National total$2.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 151 | $61.3 million |
| FY 2022 | 148 | $56.4 million |
| FY 2023 | 155 | $69.2 million |
| FY 2024 | 145 | $64.7 million |
| FY 2025 | 140 | $63.6 million |
Recipients in New York
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| New York University | Colleges and universities | 46 | $56.6 million |
| University of Rochester | Colleges and universities | 44 | $48.3 million |
| Icahn School of Medicine at Mount Sinai | Colleges and universities | 36 | $48.2 million |
| The Trustees of Columbia University in the City of New York | Colleges and universities | 47 | $40.7 million |
| The Hospital for Special Surgery Fund, Inc. | Nonprofits | 28 | $27.0 million |
| Weill Medical College of Cornell University | Colleges and universities | 12 | $22.2 million |
| Cornell University | Colleges and universities | 15 | $13.1 million |
| The Rockefeller University | Colleges and universities | 9 | $9.4 million |
| The Research Foundation for the State University of New York | Nonprofits | 4 | $6.9 million |
| Albert Einstein College of Medicine | Colleges and universities | 4 | $4.7 million |
Open opportunities under this program
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 62 on the program page
Questions people ask
How much Arthritis, Musculoskeletal and Skin Diseases Research money goes to New York?
$315 million from fiscal 2021 to 2025, across 302 awards. New York ranks 2nd of 44 states and territories for this program.
Who receives Arthritis, Musculoskeletal and Skin Diseases Research money in New York?
The largest recipient is New York University, with $56.6 million in 46 awards. Next are University of Rochester and Icahn School of Medicine at Mount Sinai.
Can organizations in New York apply now?
Yes, 62 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Arthritis, Musculoskeletal and Skin Diseases Research in other states
Other large programs in New York
- Grants to States for Medicaid
- 1332 State Innovation Waivers
- Federal Transit Formula Grants
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Highway Planning and Construction
- National School Lunch Program
- Children's Health Insurance Program
- Public Housing Operating Fund